This task is about writing a correct answer for the reading comprehension task. Based on the information provided in a given passage, you should identify the shortest continuous text span from the passage that serves as an answer to the given question. Avoid answers that are incorrect or provides incomplete justification for the question.

Passage: 
 Kazakhstan: The first torchbearer in Almaty, where the Olympic torch arrived for the first time ever on April 2, was the President of Kazakhstan Nursultan Nazarbaev. The route ran 20 km from Medeo stadium to Astana Square. There were reports that Uighur activists were arrested and some were deported back to China. Question: What activists were reported to have been arrested?
Uighur

Passage: The U.S. Navy, by contrast, relied on commerce raiding from the outset. However, the problem of Allied forces surrounded in the Philippines, during the early part of 1942, led to diversion of boats to "guerrilla submarine" missions. As well, basing in Australia placed boats under Japanese aerial threat while en route to patrol areas, reducing their effectiveness, and Nimitz relied on submarines for close surveillance of enemy bases. Furthermore, the standard-issue Mark 14 torpedo and its Mark VI exploder both proved defective, problems which were not corrected until September 1943. Worst of all, before the war, an uninformed US Customs officer had seized a copy of the Japanese merchant marine code (called the "maru code" in the USN), not knowing that the Office of Naval Intelligence (ONI) had broken it. The Japanese promptly changed it, and the new code was not broken again by OP-20G until 1943. Question: What was the "maru code"?
Japanese merchant marine code

Passage: Some of these estimates also take into account the opportunity cost of investing capital many years before revenues are realized (see Time-value of money). Because of the very long time needed for discovery, development, and approval of pharmaceuticals, these costs can accumulate to nearly half the total expense. A direct consequence within the pharmaceutical industry value chain is that major pharmaceutical multinationals tend to increasingly outsource risks related to fundamental research, which somewhat reshapes the industry ecosystem with biotechnology companies playing an increasingly important role, and overall strategies being redefined accordingly. Some approved drugs, such as those based on re-formulation of an existing active ingredient (also referred to as Line-extensions) are much less expensive to develop. Question: What drugs are the least expensive to develop?

those based on re-formulation of an existing active ingredient